Founder & CEO of Ayati Devices, a medtech company based in Bengaluru.
Nishant Kathpal is Founder & CEO of Ayati Devices, a medtech company based in Bengaluru, founded in 2019. Ayati Devices's most recent disclosed round was a Pre-Series A (Aug 2026) of $1.5M in Aug 2026.
Ayati Devices (Ayati Devices Private Limited) is a Bengaluru-based medical-technology startup founded in 2019 by Nishant Kathpal and incubated at IIT Bombay's SINE. It makes portable, point-of-care diagnostic devices, including Vibrasense, Vasosense and Angiocam, for screening diabetic foot complications, peripheral neuropathy and peripheral vascular disease.
Ayati Devices founded by Nishant Kathpal, incubated at IIT Bombay's SINE with an early BIRAC Biotechnology Ignition Grant, to build affordable diabetic-foot screening devices.
Named a winner of the Qualcomm Design in India Challenge 2023 for its diabetic peripheral neuropathy screening technology.
Appeared on Shark Tank India Season 4, securing an on-air offer of ₹1 crore for 4.76% from Namita Thapar and Peyush Bansal (at a ₹21 crore valuation).
Raised a ₹15 crore ($1.5M) pre-Series A led by Inflexor Ventures to scale commercialisation, manufacturing and international markets.
Nishant Kathpal is the Founder & CEO of Ayati Devices, a medtech company based in Bengaluru, founded in 2019.
StartupFox's company records list Nishant Kathpal as Founder & CEO of Ayati Devices.
Ayati Devices has raised $1.5M across 1 disclosed round on record. The latest was a Pre-Series A (Aug 2026) of $1.5M in Aug 2026, with Inflexor Ventures.
Ayati Devices is headquartered in Bengaluru, India.
StartupFox has published 1 story naming Nishant Kathpal; the most recent is “Ayati Devices Raises ₹15 Crore in Pre-Series A Round Led by Inflexor Ventures”.
This profile is compiled by the StartupFox desk from company announcements, regulatory filings and our own reporting. If this is you, you can verify it with LinkedIn and edit it.
